| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.00095 | 1 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.00079 | 1 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.00088 | 1 |